This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Judge trims Vyera Pharmaceuticals, Shkreli, Mulleady defenses against US FTC suit

( December 28, 2020, 23:33 GMT | Official Statement) -- MLex Summary: Vyera Pharmaceuticals and former executives Martin Shkreli and Kevin Mulleady can't assert a defense that the US Federal Trade Commission failed to allege an ongoing conspiracy, US District Judge Denise Cote ruled, granting the FTC's motion to strike the defense in its antitrust suit against Vyera and the executives. Cote also found that Shkreli can't assert defenses that he didn't possess market power as an individual and didn't enter into or sign any agreements with distributors, hospitals, API suppliers or other downstream purchasers. See document below. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Attached Documents

Related Sections